ELV. Elevated potentialELV is a margin-recovery + earnings-growth + shareholder-return story.
Main catalyst is continued improvement in Medicare/Medicaid economics.
Expectations that management delivers, on its target of at least 12% adjusted EPS growth in 2027.
Risk factors: elevated medical costs, Medicaid pressure and
Compare with Elevance Health, Inc.
22.57 USD
5.66 B USD
199.13 B USD
216.36 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
IPO date
Oct 30, 2001
ISIN
US0367521038
CUSIP
036752103
FIGI
BBG000BCG930
Identifiers
ISIN US0367521038
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Elevance Health Pullback Attracts BuyersELV is attracting buying interest following a healthy retracement. The stock remains in a confirmed uptrend, trading above its well-aligned 20-day and 50-day moving averages, indicating that the broader bullish trend remains intact.
Elevance Health, Inc. is a $90.96 billion market capitalization he
Elevance Health | ELV | Long at $286.00What are seeing in the healthcare and health insurance provider industry right now is destruction before a once-in-a-lifetime boom. The baby boomer generation is between 60 and 79 right now and the amount of healthcare service that will be needed to serve that population is staggering. Institutions
ELV (Elevance Health) – Catching the Knife or Catching Value?Elevance (ELV) just took a 12% hit after Q2 earnings missed estimates and full-year guidance was cut significantly. But here's the thing—the selloff may be overdone. The stock now trades at a forward P/E of ~10, well below industry peers, and is approaching multi-year support levels.
📥 Entry Plan
$ELV: Breakout Setting UPWhat I’m seeing
This is Elevance Health (ELV) transitioning from a corrective phase into early re-accumulation. The prior downtrend is well-defined: lower highs capped by the descending trendline and repeated BOS to the downside. That trend resolved with a sell-side liquidity sweep into discount, fo
$ELV tightening inside a contracting wedge🚨 NYSE:ELV tightening inside a contracting wedge while defending the discount zone. Liquidity has been swept, CHoCH confirmed, and price is pushing back into Equilibrium → Premium. If momentum holds, a drive toward the $348–$352 zone becomes a valid upside path.
📌 Key Observations
Higher-timefra
$ELV – Smart Money Structure & VolanX ViewNYSE:ELV – Smart Money Structure & VolanX View
Market Structure: Price is recovering from a deep discount zone with multiple internal CHoCH events confirming short-term bullish intent. Current structure shows stabilization above the 0.382–0.50 Fib zone, suggesting accumulation before expansion (Sc
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateAug 15, 2054
Coupon4.85% (Fixed)
Maturity dateNov 1, 2064
Coupon5.85% (Fixed)
Maturity dateFeb 15, 2055
Coupon5.70% (Fixed)
Maturity dateFeb 15, 2053
Coupon5.13% (Fixed)
Maturity dateJan 15, 2044
Coupon5.10% (Fixed)
Maturity dateSep 15, 2049
Coupon3.70% (Fixed)
Maturity dateSep 15, 2055
Coupon5.70% (Fixed)
Maturity dateMar 1, 2048
Coupon4.55% (Fixed)
Maturity dateJun 15, 2054
Coupon5.65% (Fixed)
Maturity dateOct 15, 2052
Coupon6.10% (Fixed)
Maturity dateMay 15, 2052
Coupon4.55% (Fixed)
See all ELV bonds
Frequently asked questions
The current price of ELV is 396.59 USD — it has increased by 2.09% in the past 24 hours. Watch Elevance Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Elevance Health, Inc. stocks are traded under the ticker ELV.
ELV stock has fallen by −0.62% compared to the previous week, the month change is a −4.04% fall, over the last year Elevance Health, Inc. has showed a 12.06% increase.
We've gathered analysts' opinions on Elevance Health, Inc. future price: according to them, ELV price has a max estimate of 492.00 USD and a min estimate of 393.00 USD. Watch ELV chart and read a more detailed Elevance Health, Inc. stock forecast: see what analysts think of Elevance Health, Inc. and suggest that you do with its stocks.
ELV stock is 1.10% volatile and has beta coefficient of 0.75. Track Elevance Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elevance Health, Inc. there?
Today Elevance Health, Inc. has the market capitalization of 85.56 B, it has decreased by −1.95% over the last week.
Yes, you can track Elevance Health, Inc. financials in yearly and quarterly reports right on TradingView.
Elevance Health, Inc. is going to release the next earnings report on Oct 21, 2026. Keep track of upcoming events with our Earnings Calendar.
ELV earnings for the last quarter are 7.45 USD per share, whereas the estimation was 6.21 USD resulting in a 19.94% surprise. The estimated earnings for the next quarter are 4.67 USD per share. See more details about Elevance Health, Inc. earnings.
Elevance Health, Inc. revenue for the last quarter amounts to 49.83 B USD, despite the estimated figure of 48.88 B USD. In the next quarter, revenue is expected to reach 49.30 B USD.
ELV net income for the last quarter is 1.46 B USD, while the quarter before that showed 1.76 B USD of net income which accounts for 0.00% change. Track more Elevance Health, Inc. financial stats to get the full picture.
Yes, ELV dividends are paid quarterly. The last dividend per share was 1.72 USD. As of today, Dividend Yield (TTM)% is 1.74%. Tracking Elevance Health, Inc. dividends might help you take more informed decisions.
Elevance Health, Inc. dividend yield was 1.95% in 2025, and payout ratio reached 27.13%. The year before the numbers were 1.77% and 25.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 6, 2026, the company has 97.1 K employees. See our rating of the largest employees — is Elevance Health, Inc. on this list?
Like other stocks, ELV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elevance Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elevance Health, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elevance Health, Inc. stock shows the buy signal. See more of Elevance Health, Inc. technicals for a more comprehensive analysis.









